News - Research, Tecfidera

Filter

Current filters:

ResearchTecfidera

Popular Filters

European neurologists expect Biogen Idec’s Tecfidera to be preferred MS drug

European neurologists expect Biogen Idec’s Tecfidera to be preferred MS drug

16-04-2014

Surveyed neurologists in France, Germany, Italy, Spain and the UK project that 16% of their diagnosed…

AubagioBiogen IdecChemistryCNS DiseasesEuropeGenzymeMajorPharmaceuticalPharmacologyPhysicianResearchSANTecfidera

Biogen Idec presents new Tecfidera data in MS at ECTRIMS

04-10-2013

Biogen Idec presented data showing that Tecfidera continues to offer consistent and strong efficacy combined…

Biogen IdecBiotechnologyNeurologicalResearchTecfidera

Alkermes reveals candidates for MS, cancer and pain

18-07-2013

US drugmaker Alkermes (Nasdaq: ALKS) has unveiled three new drug candidates for the treatment of multiple…

AlkermesBiogen IdecNeurologicalNorth AmericaOncologyPharmaceuticalResearchTecfidera

Back to top